FDA approves drug called Veozah to treat hot flashes resulting from menopause

France Nouvelles Nouvelles

FDA approves drug called Veozah to treat hot flashes resulting from menopause
France Dernières Nouvelles,France Actualités
  • 📰 CBSNews
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 68%

The FDA announced it has approved a new kind of drug to treat moderate to severe hot flashes caused by menopause.

For decades, hormone replacement therapy has been the treatmentBut use of those treatments fell sharply after results from the government-backed

in 2002 suggested taking a combination of estrogen and progestin might raise the risk of worrying conditions like breast cancer and heart disease. , though they say evidence shows that the benefits still outweigh the risks for many women struggling with symptoms. An antidepressant, paroxetine, is the main non-hormonal treatment alternative available for women. But its approval wasWhile true head-to-head studies have not been published comparing fezolinetant against menopausal hormone therapy, or MHT, research so far on the drug suggests it could be a promising alternative.

"Over the short-term, the safety and tolerability of fezolinetant and MHT appear comparable. However, longer term use of MHT carries serious increased risks," wrote the Institute for Clinical and Economic Review in a report

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

CBSNews /  🏆 87. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

FDA Approves First Drug to Treat Alzheimer's AgitationFDA Approves First Drug to Treat Alzheimer's AgitationThe antipsychotic brexpiprazole (Rexulti) is the first FDA-approved treatment option for agitation associated with Alzheimer's disease.
Lire la suite »

FDA approves nonhormonadrug to treat hot flashes and night sweatsFDA approves nonhormonadrug to treat hot flashes and night sweatsThe pills will be marketed as Veozah to treat moderate to severe hot flashes, the most common symptom caused by menopause which can last for several years or as long as a decade or more.
Lire la suite »

FDA panel backs over-the-counter sales of birth control pillFDA panel backs over-the-counter sales of birth control pillFederal health advisers said that a decades-old birth control pill should be sold without a prescription, paving the way for a likely U.S. approval of the first over-the-counter contraceptive medication.
Lire la suite »

FDA panel backs over-the-counter sale of birth control pillFDA panel backs over-the-counter sale of birth control pillFederal health advisers are recommending that a decades-old birth control pill be sold without a prescription. The unanimous vote on Wednesday by an FDA panel paves the way for what could be the 1st birth control pill available over the counter.
Lire la suite »

Vermont's new law grants strong abortion medication protectionsVermont's new law grants strong abortion medication protectionsVermont's new abortion protections would keep mifepristone available even if FDA approval is later withdrawn.
Lire la suite »



Render Time: 2025-03-07 02:42:04